Concepedia

Stephen Baker

SB

Statistics

Publications

45

Citations

2.1K

H-Index

26

Active since

1975

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (United Kingdom)

Bristol-Myers Squibb (United States)

University of York

Bristol-Myers Squibb (Germany)

Stephen Baker is an author at Eli Lilly (United States) specializing in pharmacology, medicinal chemistry, and chemistry.

ORCID

Publications per year

1975–2019

45

Publications

45

3,5‐Dihydroxyphenylglycine Is a Highly Selective Agonist for Phosphoinositide‐Linked Metabotropic Glutamate Receptors in the Rat Hippocampus

Darryle D. Schoepp, John Goldsworthy, Bryan G. Johnson et al. · Journal of Neurochemistry · 1994 · 269 citations

, , +17

Palladium catalysis in cephalosporin chemistry: general methodology for the synthesis of cephem side chains

Vittorio Farina, Stephen Baker, Daniel A. Benigni et al. · The Journal of Organic Chemistry · 1990 · 142 citations

, , +11

(+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors

Barry P. Clark, Stephen Baker, John Goldsworthy et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 134 citations

, , +12

Palladium-catalyzed coupling between cephalosporin derivatives and unsaturated stannanes: A new ligand for palladium chemistry

Vittorio Farina, Stephen Baker, Daniel A. Benigni et al. · Tetrahedron Letters · 1988 · 91 citations

, , +11

Evidence for multiple leukotriene D4 receptors in smooth muscle

Jerome H. Fleisch, Lynn E. Rinkema, Stephen Baker · Life Sciences · 1982 · 91 citations

, , +14

1–5 of 45